На информационном ресурсе применяются рекомендательные технологии (информационные технологии предоставления информации на основе сбора, систематизации и анализа сведений, относящихся к предпочтениям пользователей сети "Интернет", находящихся на территории Российской Федерации)

whotrades

13 подписчиков

Meissa Vaccines Appoints Dr. Lawrence Blatt as Chairman of the Board of Directors

SOUTH SAN FRANCISCO, Calif., March 13, 2018 /PRNewswire/ -- Meissa Vaccines, a biotechnology company developing vaccines to prevent viral respiratory infections, announced that Lawrence M. Blatt, Ph.D., MBA was appointed chairman of the company's board of directors. Dr. Blatt has more than 29 years of drug research and development experience with a specific focus on biology of the immune system, infectious diseases, antiviral therapies, and relevant therapeutic interventions.

Until recently, he was the Global Head of Infectious Diseases and Vaccines at Johnson & Johnson. Dr. Blatt is a serial biotech entrepreneur, who founded Alios BioPharma, which developed therapies for viral diseases, including respiratory syncytial virus (RSV) and hepatitis C. Dr. Blatt is also the recipient of numerous prestigious awards including the E&Y Entrepreneur of the Year award for life sciences for San Francisco Bay area in 2012.

Ссылка на первоисточник
наверх